We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.

#liver #PortalHypertension #clinicaltrails #cACLD
Introducing MOTION WP 1 - Focusing on pathophysiological mechanisms in compensated Patients with liver cirrhosis....

🌐More info in the video below 🌐 🔽🔽

Neben PubMed sind jetzt auch ClinicalTrails und die Uniklinik Erlangen mit ihrem LongCovid Forschungsprojekt angezapft. Inzwischen sind es bereits um die 1000 Artikel in der Datenbank. Ich rechne mit ca zwei Wochen bis zum Launch.

🌐 Introducing MOTION WorkPackage 2 by @reibergerthomas.bsky.social 🌐

In this particular WP the team is focusing on decompensated cirrhosis..
#liver #PortalHypertension #clinicaltrails #dACLD

🔽 Find out more in the video below 📷🔽

It is not going to happen. This is lousy PR stunt from Musk. If you read the Neuralink press release, it sounds like it is a self- congratulatory note sent by a graduate student to impress his mentor.

Jokes aside, there is no trial registered on Clinicaltrails. Gov for Neuralink.